Evidence map›Paper›PMID 30145666›Full record

ReviewBiotechnology letters2018

Marine derived biosurfactants: a vast potential future resource.

Lakshmi Tripathi, Victor U Irorere, Roger Marchant, Ibrahim M Banat

Abstract readReview
In one paragraph

Review in Biotechnology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. High-quality physiology ofFrontiers in bioengineering and biotechnology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lakshmi TripathiSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, BT52 1SA, UK.
Victor U IrorereSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, BT52 1SA, UK.
Roger MarchantSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, BT52 1SA, UK.
Ibrahim M BanatSchool of Biomedical Sciences, Faculty of Life and Health Sciences, Ulster University, Coleraine, BT52 1SA, UK. im.banat@ulster.ac.uk.ORCID http://orcid.org/0000-0001-8964-2840

Funding

Horizon 2020 635340
6 · The paper itself

Abstract

Surfactants and emulsifiers are surface-active compounds (SACs) which play an important role in various industrial processes and products due to their interfacial properties. Many of the chemical surfactants in use today are produced from non-renewable petrochemical feedstocks, while biosurfactants (BS) produced by microorganisms from renewable feedstocks are considered viable alternatives to petroleum based surfactants, due to their biodegradability and eco-friendly nature. However, some well-characterised BS producers are pathogenic and therefore, not appropriate for scaled-up production. Marine-derived BS have been found to be produced by non-pathogenic organisms making them attractive possibilities for exploitation in commercial products. Additionally, BS produced from marine bacteria may show excellent activity at extreme conditions (temperature, pH and salinity). Despite being non-pathogenic, marine-derived BS have not been exploited commercially due to their low yields, insufficient structural elucidation and uncharacterised genes. Therefore, optimization of BS production conditions in marine bacteria, characterization of the compounds produced as well as the genes involved in the biosynthesis are necessary to improve cost-efficiency and realise the industrial demands of SACs.

Indexed as

Biodegradation, EnvironmentalSurface-Active AgentsAquatic OrganismsBacteriaEmulsifying AgentsEmulsifying AgentsSurface-Active AgentsBiodegradableBioremediationBiosurfactantEmulsifierMarine bacteriaSurface-active

Identifiers

PMID30145666
PMCPMC6223728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.